𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

✍ Scribed by Christopher R. Chapple; Steven A. Kaplan; David Mitcheson; Jiri Klecka; Jana Cummings; Ted Drogendijk; Caroline Dorrepaal; Nancy Martin


Book ID
118441014
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
508 KB
Volume
63
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES